APIEXTRACTION OF BIOMEDICAL DATA
TECHNOLOGY
Proprietary infrastructure allows for faster data extraction from broad biomedical literature, resulting in accurate analyses
FEATURES
caption and embedded text search, similarity search, classification, segmentation
PRODUCTS
DATA
SCIENTISTS
-
Image
search -
Image segmentation
-
Image classification
-
Text
Search -
Language Detection
-
Entity Recognition
-
Sentiment
Analysis -
Biomedical ontology detection
-
Sentence structure analysis
MARKET & COMPETITOR INTELLIGENCE
-
Market analytics: products, locations, competitors
-
Authors contact information
TEAM
O'LEARY Co-founder & CEO
Anna has a business background in Economics and Finance, with previous experience in investment banking. Since stepping into the Life Science industry 8 years ago, Anna was part of the first agency to distribute CRISPR technology to European customers, becoming a co-founder at BioXplor and being featured in Forbes as one of the "Women-led founders driving the future of HealthTech".
KARTASEVS Co-founder and CTO
Pavel is a highly skilled engineer with a passion for bioinformatics software development in genomics, proteomics and metabolomics. He has a background in MEng Computer Science from Riga Technical University and Msc Applied Bioinformatics from Cranfield University. He has particular expertise in biological data classification and recognition of machine learning approaches using GPGPU-based predictive modelling.
BELKHIRI MBA, MAS
Health Innovation, Digital Health, Medical Devices, Clinical, Global Strategy, AI, Deeptech, Ethics, Digital Intelligence, Health Care in Metaverse & Nanoverse, Digital Biomarkers.
Bioengineer and PhD in Biological Sciences, with development in genetics and genomics.
CONWAY MSC, PHD
A consulting Data Scientist with multi-industry experience in analytics, machine learning and management.
O'LEARY Co-founder & CEO
Anna has a business background in Economics and Finance, with previous experience in investment banking. Since stepping into the Life Science industry 8 years ago, Anna was part of the first agency to distribute CRISPR technology to European customers, becoming a co-founder at BioXplor and being mentioned in Forbes as one of the "Women-led founders driving the future of HealthTech".
ALLISON
Innovative CTO, VP Engineering, Engineering Director and People Leader.
KWON MBA, MD PHD
Life Science and Healthcare Executive - Drug Development, Medical Affairs, Digital Transformation.
WALLACH MSC, MBA, MSE
A successful entrepreneur, management consultant, board member, advisor and seasoned senior executive in Biotechnology, Pharmaceuticals, Devices, Diagnostics and Spacecraft & Space Systems. Todd started and built innovative companies with market capitalization of >$2B, raised over $80M in capital, including $4.5M in grant funding and has multiple exits with strong return.